Basal Cell Nevus Syndrome
📧 Sign up to get email alerts when something new happens for Basal Cell Nevus Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Reproductive Options in Inherited Skin Diseases
A clinical trial update indicates a study on reproductive options for inherited skin diseases is ongoing at Maastricht University Medical Ce…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Maastricht University Medical Center is conducting a qualitative study to explore reproductive counseling for patients with genodermatoses a…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma [Phase 1]
A Phase 1 clinical trial at Case Comprehensive Cancer Center evaluating Vitamin D as a nutritional neoadjuvant during photodynamic therapy f…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) [Phase 3]
Phase 3 extension study of patidegib topical gel 2% for Basal cell nevus syndrome (Gorlin syndrome) has been terminated and results have bee…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) [Phase 3]
Phase 3 trial results for patidegib topical gel 2% aimed at reducing disease burden in Basal cell nevus syndrome have been posted after comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor [Phase 2]
Phase 2 trial evaluating ASN-002 with a Hedgehog pathway inhibitor in basal cell carcinoma and basal cell nevus syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) [Phase 2]
Phase 2 trial assessing the efficacy and safety of GDC-0449 in patients with Basal Cell Nevus Syndrome (Gorlin syndrome) has completed with …
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas [Phase 2]
Phase 2 trial comparing intermittent vismodegib with photodynamic therapy in patients with basal cell carcinoma associated syndromes has com…
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients [Phase 2]
A Phase 2 trial evaluating patidegib gel at 2% and 4% versus vehicle to reduce surgically eligible basal cell carcinomas in Basal Cell Nevus…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of sonidegib and buparlisib in advanced or metastatic basal cell carcinoma was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of ASN-002 in adults with low-risk nodular basal cell carcinoma, focusing …
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome [NA]
This document reports on a study of BMS-833923 in two patients with Basal Cell Nevus Syndrome. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome [NA]
Clinical trial comparing blue vs red light during Levulan-based photodynamic therapy in Basal Cell Nevus Syndrome has completed with results…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants [Phase 1]
A Phase 1 trial evaluating topical sirolimus in patients with Basal Cell Nevus Syndrome and in healthy participants has completed, reporting…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back [Phase 2]
Phase 2 clinical trial evaluating topical tazarotene for basal cell carcinoma and basal cell nevus syndrome on the chest and back has comple…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face [Phase 2]
Phase 2 trial of topical tazarotene for basal cell skin cancer and basal cell nevus syndrome on the face has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer [Phase 1]
Phase 1 study of BMS-833923 (XL139), a hedgehog pathway inhibitor, in advanced or metastatic cancer. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome [Phase 2]
This Phase 2 trial evaluating Celecoxib for preventing basal cell carcinomas in Basal Cell Nevus Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
A completed clinical trial evaluating SPF30 sunscreen and an after-sun lotion in individuals at risk for skin cancer, including those with X…